U.S. markets close in 4 hours 49 minutes
  • S&P 500

    4,135.02
    -28.24 (-0.68%)
     
  • Dow 30

    33,830.02
    -247.61 (-0.73%)
     
  • Nasdaq

    13,795.05
    -119.72 (-0.86%)
     
  • Russell 2000

    2,183.05
    -48.96 (-2.19%)
     
  • Crude Oil

    61.62
    -1.76 (-2.78%)
     
  • Gold

    1,775.70
    +5.10 (+0.29%)
     
  • Silver

    25.95
    +0.11 (+0.44%)
     
  • EUR/USD

    1.2051
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.5750
    -0.0260 (-1.62%)
     
  • GBP/USD

    1.3948
    -0.0036 (-0.26%)
     
  • USD/JPY

    108.1200
    -0.0300 (-0.03%)
     
  • BTC-USD

    55,420.41
    -751.42 (-1.34%)
     
  • CMC Crypto 200

    1,253.88
    +19.46 (+1.58%)
     
  • FTSE 100

    6,862.42
    -137.66 (-1.97%)
     
  • Nikkei 225

    29,100.38
    -584.99 (-1.97%)
     

NantHealth to Report 2020 Second-Quarter Financial Results and Host Conference Call on Thursday, August 6

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 second quarter on Thursday, August 6, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.

The conference call will be available to interested parties by dialing 800-708-4540 from the U.S. or Canada, or 847-619-6397 from international locations, passcode 49876109. The call will be broadcast via the Internet at www.nanthealth.com.

About NantHealth, Inc.

NantHealth, a member of the NantWorks ecosystem of companies, provides leading solutions across the continuum of care for physicians, payers, patients and biopharmaceutical organizations. NantHealth enables the use of cutting-edge data and technology toward the goals of empowering clinical decision support and improving patient outcomes. NantHealth’s comprehensive product portfolio combines the latest technology in payer/provider platforms that exchange information in near-real time (NaviNet and Eviti), and molecular profiling services that combine comprehensive DNA & RNA tumor-normal profiling with pharmacogenomics analysis (GPS Cancer®). For more information, please visit nanthealth.com or follow us on Twitter, Facebook and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200803005553/en/

Contacts

Robert Jaffe
424.288.4098
rjaffe@rjaffeco.com
Investor Contact: